Volume Spike Investor

Novavax, Inc. (NASDAQ: NVAX) is trading up again on swine flu or H1N1 news.  The company issued a press release showing positive clinical results from a pivotal study of H1N1 influenza vaccine in Mexico.  At 8:21 AM EST we have seen 319,000 shares trade hands and the stock is up 7.1% at $3.44.  Average volume [...]

Novavax, Inc. (NASDAQ: NVAX) may show how little key impact news there is, but it is the top mover today in percentage terms seen.  At 8:28 AM EST we have seen 75,000 shares trade (versus 6 million average) and the stock is up 6.6% at $3.20.  This is on news that it has completed enrollment [...]

Novavax, Inc. (Nasdaq: NVAX) is trading down this morning on reports from the company that it plans to offer common stock in a public secondary offering through Piper Jaffray and Lazard Capital Markets.  Terms were not yet stated, but the shares at 8:10 AM EST are down 10% at $3.38 on about 30,000 shares. Average [...]

Novavax, Inc. (NASDAQ: NVAX) is trading higher after it announced that it began a two-stage clinical study of its virus-like particle H1N1 influenza vaccine in Mexico.  This is in collaboration with Avimex Laboratories and GE Healthcare. Shares were indicated up around 9% in early trading, but at 8:20 AM EST we have seen some 400,000 [...]

Novavax, Inc. (NASDAQ: NVAX) is rising sharply after it was awarded a National Institute of Health grant for Respiratory Syncytial Virus (RSV) vaccine program.  Be advised that the SBIR grant is valued at approximately $246,000…. At 9:06 AM EST we have seen 392,000 shares trade hands and the stock is up 7.6% at $3.95.  Average [...]

Novavax Inc. (NASDAQ: NVAX) is getting spanked this morning. The swine flu stock and flu stock is trading lower after Oppenheimer & Co. downgraded the biotechnology company after shares went above and beyond the firm;s $6.00 price target.  The rating is now “Perform” rather than “Outperform” as before.   At the 9:30 Opening Bell NVAX is [...]

Novavax, Inc. (NASDAQ: NVAX) is soaring on positive flu data.  As of 8:34 AM EST we have seen almost 2 million shares trade hands versus average volume of 7 million shares.  The price is surging as well by 14% to $6.91.  Chalk this up as a 52-week high as the old high was $6.30 before [...]

There was similar news affecting HGSI, but the other swine flu or H1N1 flu stocks are getting attention as well after the Obama administration has signaled that it will help companies where it can to deliver faster and higher doses of the H1N1 flu vaccine.  The goal is to get a September increase rather than [...]

Novavax Inc. (NASDAQ: NVAX) is soaring on news that its experimental H1N1 swine flu vaccine was effective in animal tests.  The vaccine won’t be approved nor ready for commercial use in humans for two years.  At 8:53 AM EST we have already seen over 650,000 shares trade hands and th last print has the stock [...]

Novavax, Inc. (Nasdaq: NVAX) is soaring on high volume.  The company has manufactured a virus-like particle vaccine candidate against the H1N1 pandemic influenza virus (Swine Flu) under current good-manufacturing practices in the Rockville, MD facilities in only 11 weeks after receiving the gene sequence for the H1N1 strain from the CDC….  Novavax has produced essential [...]